GLP-1 and GLP-1RAs promote the expansion of -cell mass by stimulating -cell proliferation, inducing islet neogenesis, and inhibiting -cell apoptosis (Wajchenberg, 2007)
Polymorphisms in GSTT1, GSTM1, NAT2, and CYP3A4 affect glutathione synthesis capacity and drug-metabolizing enzyme activity
Researchers still need more information about people already using insulin or sulfonylureas, people with kidney or liver disease, and people with cardiovascular risk factors
Long-term Safety Considerations The long-term safety profile observed in the SELECT study is consistent with previously reported semaglutide studies, with no new safety concerns identified for once-weekly semaglutide 2.4 mg [54]
Its not imagined
So why is it ok to have no homocysteine as shown here